Botulinum Neurotoxin Revisited – An Individualised, Patient-centric Approach for the Treatment of Dystonia and Spasticity (CROSBI ID 227305)
Prilog u časopisu | pregledni rad (stručni)
Podaci o odgovornosti
Relja, Maja ; Jacinto, Jorge ; Jankovic, Joseph ; Albanese, Alberto
engleski
Botulinum Neurotoxin Revisited – An Individualised, Patient-centric Approach for the Treatment of Dystonia and Spasticity
Botulinum toxin (BoNT-A) has become first line of therapy in cervical dystonia, blepharospasm and spasticity. However, the current guidelines for the clinical use of BoNT-A are based on data publishem more than 20 years ago and patient satisfaction with current regiments is low. There is a need to optimise and individualise the treatment using the three available formulation of BoNT-A, as well as define parameters for switching between the formulations.
Botulinum toxin ; blepharospasm ; spasticity ; cervical dystonia ; Incobotulinumtoxin A
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
10 (1)
2015.
28-34
objavljeno
1758-3837
1758-3845
10.17925/ENR.2015.10.01.28
Povezanost rada
Kliničke medicinske znanosti